Emergence in Asian Countries of Staphylococcus aureus with Reduced Susceptibility to Vancomycin

ABSTRACT To investigate the prevalence of Staphylococcus aureus with reduced susceptibility to vancomycin among methicillin-resistant S. aureus (MRSA) strains in Asian countries, a total of 1,357 clinical isolates of MRSA collected from 12 Asian countries were screened by using brain heart infusion agar plates containing 4 mg of vancomycin per liter. The presence of strains that were heterointermediately resistant to vancomycin (hVISA) was confirmed by population analysis. Of 347 (25.6%) MRSA isolates that grew on the screening agar plates, 58 isolates (4.3%) were hVISA. hVISA strains were found in India, South Korea, Japan, the Philippines, Singapore, Thailand, and Vietnam. However, neither vancomycin-intermediate S. aureus nor vancomycin-resistant S. aureus isolates were found among MRSA isolates from Asian countries in this survey.

[1]  Vancomycin-resistant Staphylococcus aureus--New York, 2004. , 2004, MMWR. Morbidity and mortality weekly report.

[2]  F. Durand,et al.  Prevalence, Molecular Epidemiology, and Clinical Significance of Heterogeneous Glycopeptide-Intermediate Staphylococcus aureus in Liver Transplant Recipients , 2003, Journal of Clinical Microbiology.

[3]  H. Chambers,et al.  Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic Methods , 2003, Antimicrobial Agents and Chemotherapy.

[4]  M. Moore,et al.  Vancomycin Treatment Failure Associated with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus in a Patient with Endocarditis and in the Rabbit Model of Endocarditis , 2003, Antimicrobial Agents and Chemotherapy.

[5]  C. Pai,et al.  Clonal Spread of Staphylococcus aureus Heterogeneously Resistant to Vancomycin in a University Hospital in Korea , 2002, Journal of Clinical Microbiology.

[6]  Robert E. Johnson,et al.  From the Centers for Disease Control. Staphylococcus aureus resistant to vancomycin--United States, 2002. , 2002, JAMA.

[7]  R. Howe,et al.  The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus. , 2002, Annual review of microbiology.

[8]  K. Hiramatsu.  Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. , 2001, The Lancet. Infectious diseases.

[9]  A. MacGowan,et al.  Evaluation of Current Methods for Detection of Staphylococci with Reduced Susceptibility to Glycopeptides , 2001, Journal of Clinical Microbiology.

[10]  R N Jones,et al.  Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  K. Hiramatsu,et al.  Vancomycin-resistant Staphylococcus aureus occurs in South Africa. , 2000, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[12]  C. Pai,et al.  Vancomycin-Intermediate Staphylococcus aureus in Korea , 2000, Journal of Clinical Microbiology.

[13]  H. Sahl,et al.  Presence of Staphylococcus aureus with Reduced Susceptibility to Vancomycin in Germany , 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[14]  K. Yuen,et al.  Bacteremia caused by staphylococci with inducible vancomycin heteroresistance. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  J. Verhoef,et al.  Susceptibility of 302 Methicillin-Resistant Staphylococcus aureus Isolates from 20 European University Hospitals to Vancomycin and Alternative Antistaphylococcal Compounds , 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[16]  J. Ariza,et al.  Vancomycin in surgical infections due to meticillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin , 1999, The Lancet.

[17]  A. Tomasz,et al.  The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. , 1999, The New England journal of medicine.

[18]  M. Lessing,et al.  Vancomycin-resistant Staphylococcus aureus , 1998, The Lancet.

[19]  Y. Fukuchi,et al.  Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin , 1997, The Lancet.

[20]  F. Tenover,et al.  Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. , 1997, The Journal of antimicrobial chemotherapy.